New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 7, 2012
09:08 EDTHWD, AET, ABMD, SWHC, AMRN, BAGLOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Smith & Wesson (SWHC), up 3.9%... ALSO HIGHER: Einstein Noah (BAGL), up 8.9% after declaring $4.00 special dividend... Aetna (AET), up 1.2% after JPMorgan upgrades to Overweight... LOWER AFTER EARNINGS: Harry Winston (HWD), down 2.9%... ALSO LOWER: Amarin (AMRN), down 19.1% after announcing non-equity financing, saying continues to assess strategic alternatives... ABIOMED (ABMD), down 5.8% after an FDA panel voted to retain Class III status for certain pumps, including its Impella.
News For AET;BAGL;SWHC;HWD;AMRN;ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:38 EDTAETPrice targets raised for Managed Care Organizations at UBS
UBS raised its price targets on the Managed Care Organizations in their coverage universe. The firm cites increased volumes, a lack of new legislation, the potential for industry consolidation, and limited exposure to international markets that face a weak macro economic backdrop. UBS raised its price target on Aetna (AET) to $128 from $120, Anthem (ANTM) to $175 from $163, Cigna (CI) to $149 from $140 and United Health (UNH) to $135 from $131. UBS has a Buy rating on all four stocks.
March 24, 2015
16:20 EDTABMDOn The Fly: Closing Wrap
Subscribe for More Information
12:44 EDTABMDOn The Fly: Midday Wrap
Subscribe for More Information
11:04 EDTABMDAbiomed retraces gains, levels to watch
Subscribe for More Information
09:22 EDTABMDOn The Fly: Pre-market Movers
Subscribe for More Information
March 23, 2015
19:13 EDTABMDOn The Fly: After Hours Movers
Subscribe for More Information
17:47 EDTABMDAbiomed confirms FDA approval of Impella 2.5 heart pump
Subscribe for More Information
17:17 EDTABMDFDA approves Impella 2.5 System
The U.S. FDA approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary intervention procedures, such as balloon angioplasty and stenting, which re-open coronary arteries that are narrowed or blocked due to severe coronary artery disease. The Impella 2.5 System is manufactured by Abiomed, based in Danvers, Massachusetts. Reference Link
March 20, 2015
08:18 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gupte discusses Sustainable Growth Rate (SGR) and the proposed pay-fors and implications For Healthcare Services on an Analyst/Industry conference call to be held on March 20 at 11 am.
05:51 EDTAMRNStocks with implied volatility movement; AMRN EWG
Stocks with implied volatility movement; Amarin (AMRN) 140, iShares MSCI Germany (EWG) 20 according to iVolatility.
March 19, 2015
10:02 EDTAETOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:20 EDTAETAetna upgraded at Sterne Agee
As noted earlier, Sterne Agee upgraded Aetna to Buy from Neutral. The firm says that the company is the best-positioned name within the large-cap health plan space , a defensive sector that has little exposure to Europe and reasonable growth prospects, according to the firm.
07:17 EDTABMDStephens to hold a conference
Subscribe for More Information
06:19 EDTAETAetna upgraded to Buy from Neutral at Sterne Agee
Subscribe for More Information
March 18, 2015
12:46 EDTAETAetna, HackensackAlliance ACO announce collaboration
Subscribe for More Information
March 17, 2015
09:00 EDTAETAetna management to meet with JPMorgan
Subscribe for More Information
08:54 EDTAMRNAmarin says study suggest EPA pretreatment reduces oxidative damage
Subscribe for More Information
March 16, 2015
10:07 EDTAMRNHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use